The Einstein Medical Center Philadelphia is a non-profit hospital located in Philadelphia, Pennsylvania. The hospital is a part of the Einstein Healthcare Network. The medical center offers residency and fellowship training programs in many specialized areas.

There are 701 beds in Albert Einstein Medical Center.

During the past decade, Albert Einstein Medical Center conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 91 clinical trials were completed, i.e. on average, 162.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 28 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Einstein Medical Center" #1 sponsor was "Radiation Therapy Oncology Group" with 63 trials, followed by "National Cancer Institute (NCI)" with 28 trials sponsored, "Albert Einstein Healthcare Network" with 24 trials sponsored, "NSABP Foundation Inc" with 11 trials sponsored and "Alliance for Clinical Trials in Oncology" with 11 trials sponsored. Other sponsors include 132 different institutions and companies that sponsored additional 98 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert Einstein Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 102 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "North Central Cancer Treatment Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Albert Einstein Medical Center" are "Breast Cancer" (20 trials), "Lung Cancer" (19 trials), "Prostate Cancer" (19 trials), "Head and Neck Cancer" (14 trials) and "Metastatic Cancer" (8 trials). Many other conditions were trialed in "Albert Einstein Medical Center" in a lesser frequency.

Most popular intervention types in "Albert Einstein Medical Center" are "Drug" (182 trials), "Radiation" (65 trials), "Other" (47 trials), "Biological" (41 trials) and "Device" (37 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (39 trials), "Placebo" (32 trials), "Laboratory Biomarker Analysis" (20 trials), "cisplatin" (19 trials) and "paclitaxel" (16 trials). Other intervention names were less common.

The vast majority of trials in "Albert Einstein Medical Center" are 225 trials for "All" genders, 27 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Albert Einstein Medical Center". undefined are not yet recruiting, 16 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 179 completed trials in Albert Einstein Medical Center, undefined suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Einstein Medical Center, 15 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 34 trials that are defined as “Not Applicable".